240 related articles for article (PubMed ID: 14740779)
1. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
Lim VY; Lim YL
Singapore Med J; 2003 Sep; 44(9):482-7. PubMed ID: 14740779
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
3. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Ray GM; Nawarskas JJ; Frishman WH
Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
[TBL] [Abstract][Full Text] [Related]
4. Through the drug-eluting stent labyrinth.
Guagliumi G; Musumeci G; Vassileva A; Tespili M; Valsecchi O
Ital Heart J; 2003 Apr; 4(4):236-45. PubMed ID: 12784776
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents: preventing restenosis.
Slavin L; Chhabra A; Tobis JM
Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
[TBL] [Abstract][Full Text] [Related]
6. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
8. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
Perin EC
Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
[TBL] [Abstract][Full Text] [Related]
9. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
Halkin A; Stone GW
J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
11. [Stents without restenosis--true or a myth?].
Starcević B; Vagić JS
Acta Med Croatica; 2004; 58(2):143-6. PubMed ID: 15208801
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stents: from randomized trials to the real world.
Saia F; Degertekin M; Lemos PA; Serruys PW
Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
[TBL] [Abstract][Full Text] [Related]
13. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
14. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.
Yarkoni A; Brodsky A; Sabapathy R; Pershad A
Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stents.
Chieffo A; Colombo A
Minerva Cardioangiol; 2002 Oct; 50(5):419-29. PubMed ID: 12384624
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
17. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
Er F; Erdmann E
Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
[TBL] [Abstract][Full Text] [Related]
18. Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.
Chong PH; Cheng JW
Ann Pharmacother; 2004 May; 38(5):845-52. PubMed ID: 15039482
[TBL] [Abstract][Full Text] [Related]
19. Hybrid coronary revascularization in the era of drug-eluting stents.
Murphy GJ; Bryan AJ; Angelini GD
Ann Thorac Surg; 2004 Nov; 78(5):1861-7. PubMed ID: 15511503
[TBL] [Abstract][Full Text] [Related]
20. Restenosis treatment in the drug-eluting stent era.
Presbitero P; Boccuzzi G
Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]